David Michael Williams - 10 Feb 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP,Chief Info&Digital Officer
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for David Michael Williams
Issuer symbol
MRK
Transactions as of
10 Feb 2023
Net transactions value
+$84,522
Form type
4
Filing time
13 Feb 2023, 15:17:26 UTC
Previous filing
25 Jan 2023
Next filing
03 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $128,598 +1,205 +11% $106.72 12,505 10 Feb 2023 Direct
transaction MRK Common Stock Tax liability $44,075 -413 -3.3% $106.72 12,092 10 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -1,205 -100% $0.000000* 0 10 Feb 2023 Common Stock 1,205 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 2/10/2021, 2/10/2022 and 2/10/2023.